|
Core Support for Cancer Center
|
5P30CA013330-37
|
$3,927,232
|
$39,272
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
H/D Exchange Coupled to MS to Study Drug-Induced Change in Microtuble Structure
|
5R01CA124898-03
|
$315,400
|
$189,240
|
HORWITZ, SUSAN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Radiation Therapy Oncology Group
|
2U10CA021661-33
|
$12,534,580
|
$2,632,262
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Community Clinical Oncology Program Research Base
|
3U10CA037422-22S1
|
$26,578
|
$2,658
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Community Clinical Oncology Program Research Base
|
5U10CA037422-22
|
$1,683,081
|
$168,308
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Drug Delivery Carriers Targeted to Breast Tumor by Fusion Phage Proteins
|
5R01CA125063-03
|
$380,792
|
$95,198
|
PETRENKO, VALERY
|
AUBURN UNIVERSITY AT AUBURN
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-20
|
$521,201
|
$52,120
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
Breast cancer response markers to a dual HER1/2 blocker
|
5R01CA112305-05
|
$252,236
|
$83,238
|
CHANG, JENNY
|
BAYLOR COLLEGE OF MEDICINE
|
|
NSABP Participating Sites
|
5U10CA118735-04
|
$67,765
|
$6,099
|
CHANG, JENNY
|
BAYLOR COLLEGE OF MEDICINE
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-26
|
$430,954
|
$60,334
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Eastern Cooperative Oncology Group
|
5U10CA080775-11
|
$130,866
|
$23,556
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Dana-Farber/Harvard Cancer Center Ovarian Cancer SPORE
|
3P50CA105009-05S1
|
$1,193,174
|
$238,635
|
CRAMER, DANIEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Functional Analysis of Histologic Grade in Breast Cancer
|
5R01CA109325-05
|
$261,573
|
$13,079
|
DAIRKEE, SHANAZ
|
CALIFORNIA PACIFIC MED CTR RES INSTITUTE
|
|
Carle Cancer Center Community Clinical Oncology Program
|
5U10CA035195-26
|
$841,092
|
$100,931
|
ROWLAND, KENDRITH
|
CARLE CLINIC ASSOCIATION, P C
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-35
|
$417,370
|
$75,127
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis
|
5U01CA062502-16
|
$772,307
|
$7,723
|
DOWLATI, AFSHIN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Cedar Rapids Oncology Project
|
5U10CA052352-20
|
$446,062
|
$40,146
|
WIESENFELD, MARTIN
|
CEDAR RAPIDS ONCOLOGY PROJECT
|
|
Array-assisted Insertional Mutagenesis Platform for Forward Genetics of Cancer
|
5R43CA132841-02
|
$94,729
|
$94,729
|
CHENCHIK, ALEX
|
CELLECTA, INC.
|
|
Delaware/Christiana Care CCOP
|
5U10CA045418-23
|
$1,282,700
|
$153,924
|
Grubbs, Stephen
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
City of Hope Southwest Oncology Group Clinical Trials
|
5U10CA046368-22
|
$332,211
|
$96,341
|
MORTIMER, JOANNE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Southwest Oncology Group
|
5U10CA004919-50
|
$195,727
|
$56,761
|
BUDD, G
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Neurorestorative Strategy for Chemotherapy-induced Peripheral Neuropathy
|
1R43CA141819-01
|
$326,711
|
$163,356
|
LI, FENG-QIAO
|
COGNOSCI, INC.
|
|
CCOP: Colorado Cancer Research Program
|
5U10CA067753-14
|
$1,053,364
|
$126,404
|
Pajon, Eduardo
|
COLORADO CANCER RESEARCH PROGRAM, INC.
|
|
Total Synthesis and Biosynthesis of Bioactive Substances
|
2R01CA070375-13
|
$255,896
|
$127,948
|
WILLIAMS, ROBERT
|
COLORADO STATE UNIVERSITY-FORT COLLINS
|
|
Cancer Center Clinical Trials Reporting Program (CTRP) Early Adopters
|
3P30CA013696-36S1
|
$99,928
|
$999
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-36
|
$3,999,822
|
$39,998
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Enhanced Intraarterial Delivery of Chemotherapeutic Drugs to the Brain
|
5R01CA127500-02
|
$363,748
|
$120,037
|
JOSHI, SHAILENDRA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Columbus Community Clinical Oncology Program
|
5U10CA035261-26
|
$930,000
|
$83,700
|
KUEBLER, J
|
COLUMBUS COMMUNITY CLINICAL ONCOLOGY PRG
|
|
Cancer and Leukemia Group B
|
2U10CA032291-28
|
$413,820
|
$186,219
|
Burstein, Harold
|
DANA-FARBER CANCER INSTITUTE
|
|
ECOG Statistical Office
|
5U10CA023318-33
|
$2,407,336
|
$433,320
|
GRAY, ROBERT
|
DANA-FARBER CANCER INSTITUTE
|
|
Dayton Clinical Oncology Program
|
2U10CA035090-27
|
$1,166,703
|
$105,003
|
GROSS, HOWARD
|
DAYTON CLINICAL ONCOLOGY PROGRAM
|
|
Central Illinois Community Clinical Oncology Program
|
5U10CA045807-24
|
$1,370,000
|
$178,100
|
WADE, JAMES
|
DECATUR MEMORIAL HOSPITAL
|
|
Eastern Cooperative Oncology Group Chair's Office
|
5U10CA086802-11
|
$655,420
|
$117,976
|
COMIS, ROBERT
|
DREXEL UNIVERSITY
|
|
Cancer and Leukemia Group B
|
2U10CA047577-22
|
$157,170
|
$70,727
|
CRAWFORD, JEFFREY
|
DUKE UNIVERSITY
|
|
Cancer and Leukemia Group B Statistical Center
|
2U10CA033601-30
|
$4,929,147
|
$2,218,116
|
GEORGE, STEPHEN
|
DUKE UNIVERSITY
|
|
Nuclear EGFR Signaling Network in Human Cancer
|
5K01CA118423-04
|
$151,372
|
$30,274
|
Lo, Hui-Wen
|
DUKE UNIVERSITY
|
|
ACOSOG Non Competing Renewal
|
5U10CA076001-13
|
$3,062,358
|
$428,730
|
OTA, DAVID
|
DUKE UNIVERSITY
|
|
Duluth Community Clinical Oncology Program
|
5U10CA035269-26
|
$747,046
|
$52,293
|
Nikcevich, Daniel
|
DULUTH CLINIC, LTD.
|
|
Novel anti-melanoma agents and their mechanism of action
|
5R01CA095317-05
|
$257,865
|
$64,466
|
JOSHI, HARISH
|
EMORY UNIVERSITY
|
|
Targeting Cell Signaling in lung cancer to enhance therapeutic efficacy
|
5P01CA116676-04
|
$1,528,598
|
$764,299
|
KHURI, FADLO
|
EMORY UNIVERSITY
|
|
Emory-GA Tech Nanotechnology Center for Personalized an*
|
5U54CA119338-05
|
$3,691,806
|
$922,952
|
NIE, SHUMING
|
EMORY UNIVERSITY
|
|
SPORE in Head and Neck Cancer
|
3P50CA128613-03S1
|
$200,000
|
$36,000
|
SHIN, DONG
|
EMORY UNIVERSITY
|
|
SPORE in Head and Neck Cancer
|
5P50CA128613-03
|
$1,423,429
|
$256,217
|
SHIN, DONG
|
EMORY UNIVERSITY
|
|
EORTC DATA CENTER
|
5U10CA011488-39
|
$809,323
|
$161,865
|
Sylvester, Richard
|
EUROPEAN ORG/RES/TREATMENT/CANCER
|
|
North Shore CCOP
|
5U10CA035279-26
|
$350,000
|
$49,000
|
VINCIGUERRA, VINCENT
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
|
Community Clinical Oncology Program: FL Pediatric CCOP
|
5U10CA035157-26
|
$382,772
|
$22,966
|
TALBERT, JAMES
|
FLORIDA ASSN OF PEDIATRIC TUMOR PROG
|
|
Eastern Cooperative Oncology Group
|
5U10CA027525-31
|
$453,259
|
$81,587
|
GOLDSTEIN, LORI
|
FOX CHASE CANCER CENTER
|
|
Studies on a Novel Taxane Pump
|
5K01CA120091-03
|
$149,056
|
$149,056
|
HOPPER-BORGE, ELIZABETH
|
FOX CHASE CANCER CENTER
|
|
Southwest Oncology Group Statistical Center
|
5U10CA038926-24
|
$4,746,162
|
$1,376,387
|
CROWLEY, JOHN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
EASTERN COOPERATIVE ONCOLOGY GROUP OPERATIONS OFFICE
|
5U10CA021115-35
|
$9,256,982
|
$1,666,257
|
COMIS, ROBERT
|
FRONTIER SCI & TECHNOLOGY RSCH FDN, INC
|
Total relevant funding to Taxol for this search: $69,699,847
|